Baskies Arnold M 4

What Happened

• Arnold M. Baskies, a director of Anixa Biosciences, made an open-market purchase of 10,000 common shares on 2026-01-28. The shares were acquired at $3.04 per share for a total transaction value of $30,400.
• This was a purchase (transaction code P), which is generally considered more informative than routine sales because it represents an insider buying company stock.

Key Details

• Transaction date and price: 2026-01-28 — 10,000 shares at $3.04 per share.
• Total value: $30,400.
• Transaction type: Open-market purchase (code P).
• Shares owned after transaction: Not specified in the provided filing details.
• Filing timeliness: Report filed 2026-01-29 for a 2026-01-28 transaction — appears timely (no late-filing flag noted).
• No footnotes, 10b5-1 plan, tax withholding, or other special conditions were indicated in the provided data.

Context

• Purchases by directors can signal confidence but do not prove future performance; they are one data point among many for investors.
• This was a straightforward open-market buy (not an option exercise, gift, or award), so no immediate sale or tax-withholding mechanics apply.